Microbiome Therapeutics Market to Surge to USD 838.2 Million by 2026
According to the report, The global microbiome therapeutics market in 2019 was approximately USD 34.1 Million. The market is expected to grow above a CAGR of 58 % and is anticipated to reach over USD 838.2 Million by 2026.
The microbiome is a genetic material of all the microbes that resides within the body. The microbes contain 200 times the number of genes as compared to human genome. The microbiome consists of thousands of different bacterial species mainly in the mouth, vagina and the mouth. The gut microbiome is an important element that assist in controlling digestion and improving immunity system. The balance of microbes is very important as it may result in weight gain, high cholesterol, high blood sugar and other disorders.
Request Free Sample copy of Research Report HERE
The microbiome therapeutics market research report delivers an acute valuation and taxonomy of the microbiome therapeutics industry by practically splitting the market based on product type, application, distribution channel and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026. The regional segmentation of the microbiome therapeutics industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Further, country-wise data for the microbiome therapeutics industry is provided for the leading economies of the world.
The microbiome therapeutics market is segmented based on product type, application, distribution channel and region. On the basis of product type segmentation, the market is classified into prebiotics, probiotics, and synbiotics. On the basis of the distribution channel, the market is categorized into drug stores, super and hypermarkets, hospital pharmacies, and e-commerce stores. On the basis of the application area, the market is divided into C. difficile, Crohn’s Disease, Inflammatory Bowel Disease [IBD], Diabetes.
Request a customized copy of the report HERE
Some of the essential players operating in the microbiome therapeutics market, but not restricted to include Yakult, AbbVie Inc., Pfizer Inc., AB-Biotics, Ganeden, Vedanta Biosciences, Johnson and Johnson, Dannon, Sigma-Tau Pharmaceuticals, Bayer, and Others.
Facts & Factors
USA: 1 (347) 690-0211
Email: [email protected]